The Role of Brentuximab Vedotin (BV) as Second-Line Treatment of Refractory Classical Hodgkin Lymphoma (cHL) in the Era of Pandemic COVID-19

Autor: Rajabto,Wulyo, Chandika,Vitya, Harahap,Agnes Stephanie, Ham,Maria Francisca

Publikováno v: International Medical Case Reports Journal.

Wulyo Rajabto,1,2 Vitya Chandika,1 Agnes Stephanie Harahap,3 Maria Francisca Ham3 1Division of Hematology-Medical Oncology, Department of Internal Medicine, Dr. Cipto Mangunkusumo General Hospital/ Faculty of Medicine Universitas Indonesia, Central J

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dovemedicalp::4a86a8671963778493e4a05e853526d8
https://www.dovepress.com/the-role-of-brentuximab-vedotin-bv-as-second-line-treatment-of-refract-peer-reviewed-fulltext-article-IMCRJ

Unilateral Tonsillar Swelling as a Manifestation of Diffuse Large B Cell Lymphoma (DLBCL): Case Report.

Autor: Rajabato W; Division of Hematology-Medical Oncology, Department of Internal Medicine, Dr. Cipto Mangunkusumo General Hospital, Faculty of Medicine Universitas Indonesia., Chandika V; Division of Hematology-Medical Oncology, Department of Internal Medicine, Dr. Cipto Mangunkusumo General Hospital, Faculty of Medicine Universitas Indonesia., Harahap AS; Department of Anatomical Pathology, Dr. Cipto Mangunkusumo General Hospital/ Faculty of Medicine Universitas Indonesia.

Publikováno v: Maedica [Maedica (Bucur)] 2021 Dec; Vol. 16 (4), pp. 750-752.